Page last updated: 2024-08-22

ruthenium and Carcinoma, Non-Small Cell Lung

ruthenium has been researched along with Carcinoma, Non-Small Cell Lung in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (44.44)	24.3611
2020's	5 (55.56)	2.80

Authors

Authors	Studies
Azmanova, M; Cooper, PA; Pitto-Barry, A; Rafols, L; Seaton, CC; Shnyder, SD	1
Barbosa, MIF; Candido, CC; Doriguetto, AC; Ionta, M; Silva, HVR; Zavan, B	1
Ahmad, H; Chia, SL; Gill, MR; Saad, N; Yusoh, NA	1
Du, J; Kang, Y; Luo, Q; Wang, F; Wang, Z; Wei, Y; Zhang, Y; Zhao, Y	1
Fontrodona, X; Garcia, MH; Machuqueiro, M; Oliveira, NFB; Riganti, C; Romero, I; Salaroglio, IC; Sequeira, JGN; Teixeira, RG; Tomaz, AI; Valente, A	1
Almeida, F; Barbosa, MIF; Colina-Vegas, L; Corrêa, CC; Dias, JSM; Doriguetto, AC; Ferreira-Silva, GÁ; Ionta, M; Silva, HVR	1
Awasthi, S; Dayoub, AS; Hawkins, DL; Janaratne, T; Krishnan, A; MacDonnell, FM; Singhal, SS; Yadav, A; Yadav, S	1
Alessio, E; Baas, P; Beijnen, JH; Burgers, SA; Leijen, S; Pluim, D; Sava, G; Schellens, JH; Tibben, M; van Werkhoven, E	1
Boscutti, G; Dalla Via, L; Fregona, D; Marchiò, L; Nagy, EM; Pettenuzzo, A	1

Trials

1 trial(s) available for ruthenium and Carcinoma, Non-Small Cell Lung

Article	Year
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy. Investigational new drugs, 2015, Volume: 33, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Dimethyl Sulfoxide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Organometallic Compounds; Ruthenium; Ruthenium Compounds; Treatment Outcome	2015

Article

Year

Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy.

Investigational new drugs, 2015, Volume: 33, Issue:1

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Dimethyl Sulfoxide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Organometallic Compounds; Ruthenium; Ruthenium Compounds; Treatment Outcome

2015

Other Studies

8 other study(ies) available for ruthenium and Carcinoma, Non-Small Cell Lung

Article	Year
Anticancer Water-Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation. Chembiochem : a European journal of chemical biology, 2022, 09-16, Volume: 23, Issue:18 Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Coordination Complexes; Drug Screening Assays, Antitumor; Female; Humans; Ligands; Lung Neoplasms; Organophosphorus Compounds; Ovarian Neoplasms; Phosphines; Reactive Oxygen Species; Ruthenium; Water	2022
Synthesis, characterization and in vitro cytotoxicity of ruthenium(II) metronidazole complexes: Cell cycle arrest at G1/S transition and apoptosis induction in MCF-7 cells. Journal of inorganic biochemistry, 2022, Volume: 237 Topics: 2,2'-Dipyridyl; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line, Tumor; Coordination Complexes; Humans; Ligands; Lung Neoplasms; MCF-7 Cells; Metronidazole; Ruthenium	2022
Synergy of ruthenium metallo-intercalator, [Ru(dppz) Scientific reports, 2023, 01-26, Volume: 13, Issue:1 Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; DNA; Humans; Intercalating Agents; Lung Neoplasms; Phthalazines; Poly(ADP-ribose) Polymerase Inhibitors; Ruthenium; Zebrafish	2023
Ruthenium(II) polypyridyl complexes with visible light-enhanced anticancer activity and multimodal cell imaging. Dalton transactions (Cambridge, England : 2003), 2023, Sep-13, Volume: 52, Issue:35 Topics: Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Humans; Ligands; Light; Lung Neoplasms; Ruthenium	2023
Fighting Multidrug Resistance with Ruthenium-Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition. Journal of medicinal chemistry, 2023, 10-26, Volume: 66, Issue:20 Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cisplatin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Molecular Docking Simulation; Ruthenium; Ruthenium Compounds	2023
Pro-apoptotic activity of ruthenium 1-methylimidazole complex on non-small cell lung cancer. Journal of inorganic biochemistry, 2018, Volume: 187 Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Coordination Complexes; Humans; Imidazoles; Lung Neoplasms; Ruthenium	2018
Regression of lung cancer by hypoxia-sensitizing ruthenium polypyridyl complexes. Molecular cancer therapeutics, 2013, Volume: 12, Issue:5 Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; DNA Cleavage; Humans; Inhibitory Concentration 50; Lung Neoplasms; Male; Mice; Mice, Nude; Ruthenium; Tumor Burden; Xenograft Model Antitumor Assays	2013
Ruthenium(II/III)-based compounds with encouraging antiproliferative activity against non-small-cell lung cancer. Chemistry (Weinheim an der Bergstrasse, Germany), 2012, Nov-05, Volume: 18, Issue:45 Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Coordination Complexes; Crystallography, X-Ray; Humans; Lung Neoplasms; Molecular Conformation; Organometallic Compounds; Ruthenium	2012